Pfizer Sues Wockhardt To Block Lyrica Generic

Law360, Washington (January 28, 2013, 2:46 PM EST) -- Pfizer Inc. and Northwestern University sued Wockhardt Ltd. in Delaware federal court on Friday in an effort to stop the generic-drug maker from gaining approval to sell a generic version of the blockbuster nerve pain drug Lyrica.

Mumbai, India-based Wockhardt filed an abbreviated new drug application to the U.S. Food and Drug Administration to create its own version of the pregabalin oral solution, saying Northwestern's patent-in-suit is invalid or wouldn't be infringed by the generic competition.

Northwestern was awarded the patent-in-suit — U.S. Patent Number 6,197,819...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.